Amylyx Pharmaceuticals, Inc. (AMLX) analyst actions
AMLX analyst actions moved a median of +2.40% by the close. Rating and price-target actions on AMLX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AMLX overview →
10 measured AMLX analyst action events.
Where these AMLX analyst actions landedvs 10 measured AMLX analyst action reactions
| Middle 50% of AMLX analyst action reactions | -0.66% to +3.30% |
|---|---|
| Median reaction (to close) | +2.40% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 AMLX analyst action events with a measured close landed between -0.66% and +3.30%; 70% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Reach Out | Press release | +0.00% | +2.35% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out | Press release | -1.13% | -5.93% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Reach Out | Press release | -1.13% | -3.19% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Reach Out | Press release | -0.13% | -1.27% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out | Press release | +1.96% | +8.90% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Reach Out | Press release | +1.61% | +3.52% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out | Press release | +2.33% | +5.23% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out | Press release | +0.58% | +2.63% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out | Press release | +0.04% | +1.19% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out | Press release | +0.98% | +2.45% |
Keep exploring
More AMLX: earnings → · SEC filings → · AMLX overview →